Clinical Trial Update: Eflornithine in Treating Patients With Bladder Cancer [Phase 3]

View source ↗

Summary

This update notes the completion of a Phase 3 trial evaluating eflornithine for bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Eflornithine (eflornithine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Bladder Cancer | Phase 3 | Status: COMPLETED